|
2M04
Solution structure of BCL-xL in complex with PUMA BH3 peptide
Deposited 2012-10-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
130–154(25 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298.1 K;Ionic strength (raw mmCIF value) 50;Pressure ambient
NMR sample composition
0.9 mM [U-100% 13C; U-100% 15N; U-95% 2H; Ile,Leu,Val C1H3] BCL-xL, 0.9 mM PUMA BH3, 92% H2O/8% D2O | 92% H2O/8% D2O
NMR sample composition
0.9 mM [U-100% 13C; U-100% 15N] BCL-xL, 0.9 mM PUMA BH3, 92% H2O/8% D2O | 92% H2O/8% D2O
|
Resolution not provided
|
|
4HNJ
Crystallographic structure of BCL-xL domain-swapped dimer in complex with PUMA BH3 peptide at 2.9A resolution
Deposited 2012-10-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
130–154(25 aa)
Fragment:BH3 domain peptide
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;291 K;0.2 M CaCl2, 0.1 M NaOAc, 20% V/V isopropanol, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.90 Å
R-free 0.254
|
|
5UUL
Human Bfl-1 in complex with PUMA BH3
Deposited 2017-02-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
132–154(23 aa)
Fragment:UNP residues 132-154
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;1.8 M ammonium sulfate, 0.1 M MES pH 7.0
|
Resolution 1.33 Å
R-free 0.155
|
|
6QFM
Structure of human Mcl-1 in complex with PUMA BH3 peptide
Deposited 2019-01-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
127–149(23 aa)
|
Not recorded
|
ZN ZINC ION × 3
CL CHLORIDE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;100 mM imidazole buffer pH 7.0, 50 mM zinc acetate and 20-25% polyethylene glycol (PEG) 3350
|
Resolution 2.00 Å
R-free 0.261
|
|
6QG8
Structure of human Bcl-2 in complex with PUMA BH3 peptide
Deposited 2019-01-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
127–149(23 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;284 K;from 0.2M MgCl2, 25% PegMME 2k, 0.1M Na Acetate buffer pH 5.5
|
Resolution 1.90 Å
R-free 0.216
|
|
6TQP
Structural insight into tanapoxvirus mediated inhibition of apoptosis
Deposited 2019-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
130–155(26 aa)
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;0.1 M Potassium thiocyanate, 30% PEG 2000MME
|
Resolution 1.85 Å
R-free 0.218
|
|
7DVD
The crystal structure of p53 DNA binding domain and PUMA complex
Deposited 2021-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
136–150(15 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293.15 K;0.1 M Tris (pH 7.0)
20% (w/w) PEG-200 MME
|
Resolution 2.59 Å
R-free 0.318
|
|
7P9W
Epstein-Barr virus encoded apoptosis regulator BHRF1 in complex with Puma BH3
Deposited 2021-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
130–155(26 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 3
EDO 1,2-ETHANEDIOL × 6
NH4 AMMONIUM ION × 1
PDO 1,3-PROPANDIOL × 2
MG MAGNESIUM ION × 5
CL CHLORIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4 M Ammonium phosphate monobasic
|
Resolution 2.00 Å
R-free 0.257
|
|
7QTX
Kaposi sarcoma associated herpes virus (KSHV) encoded apoptosis inhibitor, KsBcl-2 in complex with Puma BH3
Deposited 2022-01-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
130–155(26 aa)
|
Not recorded
|
BR BROMIDE ION × 3
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.2 M sodium bromide, 0.1 M Bis-tris propane pH 6.5, 20% PEG 3350
|
Resolution 2.12 Å
R-free 0.257
|